What amount sold does IVIVA Medical, Inc. report in Form D filings?

The latest linked filings report $0 sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was IVIVA Medical, Inc.'s most recent SEC filing?

IVIVA Medical, Inc.'s most recent Form D filing was on 2018-03-26.

What type of securities does IVIVA Medical, Inc. offer?

IVIVA Medical, Inc.'s SEC Form D filings indicate equity offerings.

IVIVA Medical, Inc.

CIK: 0001732139·Biotechnology·BEVERLY, MA·Corporation·Founded 2013

Reported Sold

Total Filings

Identified Offerings

Last Filed

Mar 26, 2018

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Mar 26, 2018Form D — New notice

Reported sold: $0 · Target: $2,050,000

Rule 506(c)·0 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

$1,000,001 - $5,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Brock Reeve

Related Person

Appears on 1 filing

Harald C Ott

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 26, 2018	New	$2,050,000	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

OrthoIQ, Inc.

Biotechnology

Offering target: $1,400,000

Filed Oct 23, 2026